Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Martin Fuechtenbusch"'
Autor:
BRUNO GUERCI, FRANCESCO GIORGINO, KRISTINA BOYE, MARTIN FUECHTENBUSCH, ELKE HEITMANN, JEREMIE LEBREC, ANNE DIB, MARCO ORSINI FEDERICI, MARIA YU, LUIS-EMILIO GARCIA-PEREZ
Publikováno v:
Diabetes. 71
TROPHIES was a 24-month, prospective, non-comparative, observational study in adult patients with T2D initiating their first injectable glucose-lowering treatment with once-weekly dulaglutide (DU; N=1,014) or once-daily liraglutide (LIRA; N=991) in F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b64a216d9eca0f53ff290145fe234612
https://doi.org/10.2337/db22-726-p
https://doi.org/10.2337/db22-726-p
Autor:
FRANCESCO GIORGINO, BRUNO GUERCI, LUIS-EMILIO GARCIA-PEREZ, MARTIN FUECHTENBUSCH, JEREMIE LEBREC, MARCO ORSINI FEDERICI, ANNE DIB, ELKE HEITMANN, MARIA YU, KRISTINA BOYE
Publikováno v:
Diabetes. 71
TROPHIES was a 24-month, prospective, non-comparative, observational study in adult patients with T2D initiating their first injectable glucose-lowering treatment with once-weekly dulaglutide (DU; N=1,014) or once-daily liraglutide (LIRA; N=991) in F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c39fe6c90eb45b6631c1d22d7a979258
https://doi.org/10.2337/db22-746-p
https://doi.org/10.2337/db22-746-p
Autor:
MARTIN FUECHTENBUSCH, BRUNO GUERCI, FRANCESCO GIORGINO, LUIS-EMILIO GARCIA-PEREZ, ELKE HEITMANN, JEREMIE LEBREC, ANNABEL BARRETT, ANNE DIB, MARCO ORSINI FEDERICI, KRISTINA BOYE
Publikováno v:
Diabetes. 71
Data on patient-reported outcome (PRO) measures in people living with T2D who initiate injectable glucagon-like peptide-1 receptor agonist (GLP-1 RA) medication in routine clinical practice are limited. Here we present final PRO data from the TROPHIE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f5e8e06eb9893cb260968c41a07c9a2
https://doi.org/10.2337/db22-738-p
https://doi.org/10.2337/db22-738-p
Publikováno v:
Diabetes, obesitymetabolism. 21(6)
AIMS Insulin-treated patients with type 2 diabetes (T2D) and obesity are challenged in achieving body weight stability or reduction, in addition to glycaemic control. Post-hoc analyses of body weight and insulin dose data from the AWARD-4 trial invol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1157aee6283bde3bf90baa5181a4ec7
https://pubmed.ncbi.nlm.nih.gov/30737891
https://pubmed.ncbi.nlm.nih.gov/30737891
Autor:
Stephan Martin, Martin Fuechtenbusch, Andreas Fritsche, Manfred Dreyer, Bernhard Otto Boehm, Stefan Goelz
Publikováno v:
Diabetologie und Stoffwechsel. 8:S133-S143
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee240b51c50c167f2fb0d54e3a0d19e0
https://doi.org/10.1055/s-0033-1355668
https://doi.org/10.1055/s-0033-1355668
Autor:
Bernhard Otto Boehm, Thomas Haak, Stephan Martin, Manfred Dreyer, Andreas Fritsche, Stefan Goelz, Martin Fuechtenbusch
Publikováno v:
Diabetologie und Stoffwechsel. 7:33-83
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76fc71fe6ed89f9544a401db04d6b5f0
https://doi.org/10.1055/s-0031-1283876
https://doi.org/10.1055/s-0031-1283876